Literature DB >> 26810113

Membranous glomerulonephritis: histological and serological features to differentiate cancer-related and non-related forms.

Corrado Murtas1, Gian Marco Ghiggeri2.   

Abstract

Membranous nephropathy is a frequent cause of nephrotic syndrome in adults. In most patients, it appears as a primary renal disease but in about 20 % of cases membranous nephropathy is associated with systemic conditions such as systemic lupus erythematosus, infections or cancer, or with drug exposure. Reliable differentiation between primary and secondary membranous nephropathy has important implications for the patient, because of different therapeutic approaches between the different forms. The recent in vivo definition of glomerular targets of autoimmunity in idiopathic membranous nephropathy represented a real breakthrough and nowadays more than one podocyte antigen is considered in some way implicated in the pathogenesis of human membranous nephropathy. Specific antibodies against all these components have been detected in serum of patients and could become biomarkers of membranous nephropathy and/or of disease activity. In this brief review, we discuss the usefulness of newly described autoantibodies in the differential diagnosis of secondary membranous nephropathy. Histological clues for recognizing the two pathological entities are also analysed with regard to the available scientific evidence on this issue. Our evaluation shows that more research is needed to identify the best approach to reach a correct diagnosis of primary or secondary membranous nephropathy.

Entities:  

Keywords:  Anti-PLA2r; Anti-podocyte antibodies; IgG subclasses; Membranous nephropathy; Secondary membranous nephropathy

Mesh:

Substances:

Year:  2016        PMID: 26810113     DOI: 10.1007/s40620-016-0268-7

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  59 in total

1.  Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens.

Authors:  Maurizio Bruschi; Maricla Galetti; Renato Alberto Sinico; Gabriella Moroni; Alice Bonanni; Antonella Radice; Angela Tincani; Federico Pratesi; Paola Migliorini; Corrado Murtas; Franco Franceschini; Barbara Trezzi; Francesca Brunini; Rita Gatti; Regina Tardanico; Giancarlo Barbano; Giorgio Piaggio; Piergiorgio Messa; Pietro Ravani; Francesco Scolari; Giovanni Candiano; Alberto Martini; Landino Allegri; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2014-11-14       Impact factor: 10.121

Review 2.  Idiopathic membranous nephropathy: an autoimmune disease.

Authors:  Sudesh P Makker; Alfonso Tramontano
Journal:  Semin Nephrol       Date:  2011-07       Impact factor: 5.299

3.  Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI.

Authors:  Maurizio Bruschi; Renato Alberto Sinico; Gabriella Moroni; Federico Pratesi; Paola Migliorini; Maricla Galetti; Corrado Murtas; Angela Tincani; Michael Madaio; Antonella Radice; Franco Franceschini; Barbara Trezzi; Laura Bianchi; Agata Giallongo; Rita Gatti; Regina Tardanico; Andrea Scaloni; Chiara D'Ambrosio; Maria Luisa Carnevali; Piergiorgio Messa; Pietro Ravani; Giancarlo Barbano; Beatrice Bianco; Alice Bonanni; Francesco Scolari; Alberto Martini; Giovanni Candiano; Landino Allegri; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 10.121

4.  A case of phospholipase A₂ receptor-positive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis.

Authors:  Masa Knehtl; Hanna Debiec; Prochore Kamgang; Patrice Callard; Jacques Cadranel; Pierre Ronco; Jean-Jacques Boffa
Journal:  Am J Kidney Dis       Date:  2010-11-17       Impact factor: 8.860

5.  Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

Authors:  Marco Prunotto; Maria Luisa Carnevali; Giovanni Candiano; Corrado Murtas; Maurizio Bruschi; Emilia Corradini; Antonella Trivelli; Alberto Magnasco; Andrea Petretto; Laura Santucci; Silvia Mattei; Rita Gatti; Francesco Scolari; Peter Kador; Landino Allegri; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2010-02-11       Impact factor: 10.121

6.  Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.

Authors:  Elion Hoxha; Ursula Kneißler; Gesa Stege; Gunther Zahner; Ina Thiele; Ulf Panzer; Sigrid Harendza; Udo M Helmchen; Rolf A K Stahl
Journal:  Kidney Int       Date:  2012-06-06       Impact factor: 10.612

7.  Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.

Authors:  Barbora Svobodova; Eva Honsova; Pierre Ronco; Vladimir Tesar; Hanna Debiec
Journal:  Nephrol Dial Transplant       Date:  2012-12-06       Impact factor: 5.992

8.  Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.

Authors:  Durga Kanigicherla; Jennet Gummadova; Edward A McKenzie; Stephen A Roberts; Shelley Harris; Milind Nikam; Kay Poulton; Lorna McWilliam; Colin D Short; Michael Venning; Paul E Brenchley
Journal:  Kidney Int       Date:  2013-01-30       Impact factor: 10.612

9.  Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.

Authors:  Barbara Seitz-Polski; Guillaume Dolla; Christine Payré; Christophe A Girard; Joel Polidori; Kevin Zorzi; Eléonore Birgy-Barelli; Perrine Jullien; Cécile Courivaud; Thierry Krummel; Sylvia Benzaken; Ghislaine Bernard; Stéphane Burtey; Christophe Mariat; Vincent L M Esnault; Gérard Lambeau
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

10.  Rituximab treatment for membranous nephropathy: a French clinical and serological retrospective study of 28 patients.

Authors:  Pierre-Antoine Michel; Karine Dahan; Pierre-Yves Ancel; Emmanuelle Plaisier; Rachid Mojaat; Sophie De Seigneux; Eric Daugas; Marie Matignon; Laurent Mesnard; Alexandre Karras; Hélène François; Agathe Pardon; Valérie Caudwell; Hanna Debiec; Pierre Ronco
Journal:  Nephron Extra       Date:  2011-12-24
View more
  12 in total

1.  Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.

Authors:  Caixia Tian; Lian Li; Tanxin Liu; Xin Qu; Yurong Qiu
Journal:  Int Urol Nephrol       Date:  2019-06-21       Impact factor: 2.370

2.  Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.

Authors:  A Radice; F Pieruzzi; B Trezzi; G Ghiggeri; P Napodano; M D'Amico; T Stellato; R Brugnano; F Ravera; D Rolla; G Pesce; M E Giovenzana; F Londrino; V Cantaluppi; F Pregnolato; A Volpi; G Rombolà; G Moroni; G Ortisi; Renato A Sinico
Journal:  J Nephrol       Date:  2017-10-28       Impact factor: 3.902

3.  Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.

Authors:  Vincenzo L'Imperio; Federico Pieruzzi; Renato Alberto Sinico; Manuela Nebuloni; Antonio Granata; Andrew Smith; Antonella Radice; Fabio Pagni
Journal:  J Nephrol       Date:  2018-04-06       Impact factor: 3.902

4.  Anti-alpha-enolase antibodies in membranous nephropathy: isotype matters.

Authors:  Corrado Murtas; Maurizio Bruschi; Giovanni Candiano; Alice Bonanni; Gian Marco Ghiggeri
Journal:  Clin Exp Nephrol       Date:  2016-03-30       Impact factor: 2.801

Review 5.  Treatment of primary membranous nephropathy: where are we now?

Authors:  Andrea Angioi; Nicola Lepori; Ana Coloma López; Sanjeev Sethi; Fernando C Fervenza; Antonello Pani
Journal:  J Nephrol       Date:  2017-09-05       Impact factor: 3.902

6.  Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy.

Authors:  Marilina Tampoia; Francesca Migliucci; Chiara Villani; Letizia Abbracciavento; Michele Rossini; Ruggiero Fumarulo; Loreto Gesualdo; Vincenzo Montinaro
Journal:  J Nephrol       Date:  2018-09-05       Impact factor: 3.902

7.  Malignancy in Membranous Nephropathy: Evaluation of Incidence.

Authors:  Basil Alnasrallah; John F Collins; L Jonathan Zwi
Journal:  Int J Nephrol       Date:  2017-07-16

8.  Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.

Authors:  Franziska von Haxthausen; Linda Reinhard; Hans O Pinnschmidt; Michael Rink; Armin Soave; Elion Hoxha; Rolf A K Stahl
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

9.  Identification of biomarkers and drug repurposing candidates based on an immune-, inflammation- and membranous glomerulonephritis-associated triplets network for membranous glomerulonephritis.

Authors:  Chengwei Zhang; Lei Leng; Zhaozheng Li; Yao Zhao; Jundong Jiao
Journal:  BMC Med Genomics       Date:  2020-01-07       Impact factor: 3.063

Review 10.  Perspectives in membranous nephropathy.

Authors:  Nicola M Tomas; Tobias B Huber; Elion Hoxha
Journal:  Cell Tissue Res       Date:  2021-04-06       Impact factor: 4.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.